Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial

IMPORTANCE: High-flow nasal oxygen is recommended as initial treatment for acute hypoxemic respiratory failure and is widely applied in patients with COVID-19. OBJECTIVE: To assess whether helmet noninvasive ventilation can increase the days free of respiratory support in patients with COVID-19 comp...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA
Main Authors: Grieco, Domenico Luca, Menga, Luca S., Cesarano, Melania, Rosà, Tommaso, Spadaro, Savino, Bitondo, Maria Maddalena, Montomoli, Jonathan, Falò, Giulia, Tonetti, Tommaso, Cutuli, Salvatore L., Pintaudi, Gabriele, Tanzarella, Eloisa S., Piervincenzi, Edoardo, Bongiovanni, Filippo, Dell’Anna, Antonio M., Delle Cese, Luca, Berardi, Cecilia, Carelli, Simone, Bocci, Maria Grazia, Montini, Luca, Bello, Giuseppe, Natalini, Daniele, De Pascale, Gennaro, Velardo, Matteo, Volta, Carlo Alberto, Ranieri, V. Marco, Conti, Giorgio, Maggiore, Salvatore Maurizio, Antonelli, Massimo
Formato: Artigo
Idioma:Inglês
Publicado: American Medical Association 2021
Assuntos:
Original Investigation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7995134/
https://ncbi.nlm.nih.gov/pubmed/33764378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2021.4682
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares